Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Rentsch

Showing results (81-90 of 153) with videos related to

Pageof 16
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Candidate Genes from an FDA-Approved Algorithm Fail to Predict Opioid Use Disorder Risk in Over 450,000 VeteransChristal N Davis, Zeal Jinwala, Alexander S Hatoum, et al.
Journal of Hepatology|August 1, 2021
Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensationJessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
Molecular Psychiatry|September 19, 2022
Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studiesMehdi Farokhnia, Christopher T Rentsch, Vicky Chuong, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Brain penetrant calcium channel blockers do not reduce alcohol consumption: Converging results from two large independent cohort studies using electronic health recordsChristopher T Rentsch, Vanessa A Palzes, Mingjian Shi, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States VeteransChristopher T Rentsch, Farah Kidwai-Khan, Janet P Tate, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 YearsChristopher T Rentsch, Farah Kidwai-Khan, Janet P Tate, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2024
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease StatusVincent Lo Re, Craig W Newcomb, Dean M Carbonari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 25, 2019
Polypharmacy, Hazardous Alcohol and Illicit Substance Use, and Serious Falls Among PLWH and Uninfected ComparatorsJulie A Womack, Terrence E Murphy, Christopher T Rentsch, et al.
Plos Medicine|September 22, 2020
Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort studyChristopher T Rentsch, Farah Kidwai-Khan, Janet P Tate, et al.
Clinical Pharmacology and Therapeutics|February 16, 2022
ISPE-Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID-19: Opportunities and Trade-OffsGrammati Sarri, Dimitri Bennett, Thomas Debray, et al.
Pageof 16

Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Candidate Genes from an FDA-Approved Algorithm Fail to Predict Opioid Use Disorder Risk in Over 450,000 VeteransChristal N Davis, Zeal Jinwala, Alexander S Hatoum, et al.
Journal of Hepatology|August 1, 2021
Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensationJessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
Molecular Psychiatry|September 19, 2022
Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studiesMehdi Farokhnia, Christopher T Rentsch, Vicky Chuong, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Brain penetrant calcium channel blockers do not reduce alcohol consumption: Converging results from two large independent cohort studies using electronic health recordsChristopher T Rentsch, Vanessa A Palzes, Mingjian Shi, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States VeteransChristopher T Rentsch, Farah Kidwai-Khan, Janet P Tate, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 YearsChristopher T Rentsch, Farah Kidwai-Khan, Janet P Tate, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2024
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease StatusVincent Lo Re, Craig W Newcomb, Dean M Carbonari, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 25, 2019
Polypharmacy, Hazardous Alcohol and Illicit Substance Use, and Serious Falls Among PLWH and Uninfected ComparatorsJulie A Womack, Terrence E Murphy, Christopher T Rentsch, et al.
Plos Medicine|September 22, 2020
Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort studyChristopher T Rentsch, Farah Kidwai-Khan, Janet P Tate, et al.
Clinical Pharmacology and Therapeutics|February 16, 2022
ISPE-Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID-19: Opportunities and Trade-OffsGrammati Sarri, Dimitri Bennett, Thomas Debray, et al.
Pageof 16